EARLY SYMPTOMATIC IMPROVEMENT WITH GUSELKUMAB INDUCTION TREATMENT IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY

Gary R. Lichtenstein  ¹     Axel Dignass  ²     David T. Rubin  ³     Shadi Yarandi  ⁴     Gary KH Huang     Matthew Germinaro     Ye Miao     Hongyan Zhang     Jaroslaw Kierkus  ⁵     Ursula Seidler  ⁶     Atsuo Maemoto  ⁷     Jessica Allegretti  ⁸     Brian Bressler  ⁹     Laurent Peyrin-Biroulet  ^10    
1 University of Pennsylvania, Philadelphia, United States
² Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany
³ University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States
⁴ Janssen Research & Development, LLC, Spring House, United States
⁵ WIP Warsaw IBD Point, Warsaw, Poland
⁶ Medizinische Hochschule Klinik f. Gastroenterlogie, Hannover, Germany
⁷ Sapporo Higashi Tokushukai Hospital IBD Center, Sapporo, Japan
⁸ Brigham and Women´s Hospital, Boston, United States
⁹ University of British Columbia, Vancouver, Canada
¹⁰ Nancy University Hospital, Université de Lorraine, Nancy, France

Topic
IBD

Session
IL-23: Many but different? (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)